Semi-Annual Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7728388

Concept 2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
Semi-annual statement of income
Statement of income
Net sales
82,923,000,000 JPY
-11,000,000 JPY
78,496,000,000 JPY
4,438,000,000 JPY
82,935,000,000 JPY
86,836,000,000 JPY
82,537,000,000 JPY
4,328,000,000 JPY
-29,000,000 JPY
86,865,000,000 JPY
Cost of sales
36,423,000,000 JPY
38,271,000,000 JPY
Ordinary profit (loss)
8,246,000,000 JPY
7,716,000,000 JPY
Gross profit (loss)
46,500,000,000 JPY
48,564,000,000 JPY
Extraordinary income
627,000,000 JPY
37,000,000 JPY
Selling, general and administrative expenses
38,694,000,000 JPY
41,251,000,000 JPY
Extraordinary losses
448,000,000 JPY
1,161,000,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
8,424,000,000 JPY
6,592,000,000 JPY
Operating profit (loss)
7,805,000,000 JPY
264,000,000 JPY
7,308,000,000 JPY
232,000,000 JPY
7,541,000,000 JPY
7,313,000,000 JPY
7,076,000,000 JPY
34,000,000 JPY
202,000,000 JPY
7,110,000,000 JPY
Income taxes - current
1,748,000,000 JPY
655,000,000 JPY
Non-operating income
550,000,000 JPY
487,000,000 JPY
Income taxes - deferred
556,000,000 JPY
1,213,000,000 JPY
Non-operating income
Interest income
19,000,000 JPY
9,000,000 JPY
Dividend income
370,000,000 JPY
357,000,000 JPY
Income taxes
2,304,000,000 JPY
1,869,000,000 JPY
Non-operating expenses
110,000,000 JPY
84,000,000 JPY
Profit (loss)
6,119,000,000 JPY
4,723,000,000 JPY
Non-operating expenses
Interest expenses
20,000,000 JPY
22,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
50,000,000 JPY
33,000,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.